Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomas

Colorectal cancer is a common malignancy, and the incidence and mortality rates continue to rise. An important factor in the emergence of inflammation-induced colorectal carcinogenesis is elevated cyclooxygenase-2. Prostaglandin E2 (PGE2) over-production is frequently equated with cyclooxygenase-2 g...

Full description

Bibliographic Details
Main Authors: Jia Jiang, Anjie Li, Xiaolian Lai, Hanqun Zhang, Chonghong Wang, Huimin Wang, Libo Li, Yuncong Liu, Lu Xie, Can Yang, Cui Zhang, Shuoyan Lu, Yong Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1068469/full
_version_ 1797894236545220608
author Jia Jiang
Anjie Li
Xiaolian Lai
Hanqun Zhang
Chonghong Wang
Huimin Wang
Libo Li
Yuncong Liu
Lu Xie
Can Yang
Cui Zhang
Shuoyan Lu
Yong Li
author_facet Jia Jiang
Anjie Li
Xiaolian Lai
Hanqun Zhang
Chonghong Wang
Huimin Wang
Libo Li
Yuncong Liu
Lu Xie
Can Yang
Cui Zhang
Shuoyan Lu
Yong Li
author_sort Jia Jiang
collection DOAJ
description Colorectal cancer is a common malignancy, and the incidence and mortality rates continue to rise. An important factor in the emergence of inflammation-induced colorectal carcinogenesis is elevated cyclooxygenase-2. Prostaglandin E2 (PGE2) over-production is frequently equated with cyclooxygenase-2 gene over-expression. PGE2 can be assessed by measuring the level of prostaglandin’s main metabolite, PGE-M, in urine. Colorectal adenoma is a precancerous lesion that can lead to colorectal cancer. We conducted research to evaluate the association between urinary levels of the PGE-M and the risk of colorectal adenomas. In a western Chinese population, we identified 152 cases of adenoma and 152 controls patients without polyps. Adenoma cases were categorized into control, low-risk and high-risk groups. There was no significant change in PGE-M levels, between the control group and the low-risk adenoma group. In the high-risk group, the PGE-M levels were 23% higher than the control group. When compared to people with the lowest urine PGE-M levels (first quartile), people with greater urinary PGE-M levels had a higher chance of developing high-risk colorectal adenomas, with an adjusted odds ratio (95% CI) of 1.65 (0.76-3.57) in the fourth quartile group, (p= 0.013). We conclude urinary PGE-M is associated with the risk of developing high-risk adenomas. Urinary PGE-M level may be used as a non-invasive indicator for estimating cancer risk.
first_indexed 2024-04-10T07:05:47Z
format Article
id doaj.art-104d918ac47f4adb85eac4258168887a
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-10T07:05:47Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-104d918ac47f4adb85eac4258168887a2023-02-27T07:28:10ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-02-011310.3389/fonc.2023.10684691068469Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomasJia Jiang0Anjie Li1Xiaolian Lai2Hanqun Zhang3Chonghong Wang4Huimin Wang5Libo Li6Yuncong Liu7Lu Xie8Can Yang9Cui Zhang10Shuoyan Lu11Yong Li12Guizhou University of Traditional Chinese Medicine, Guiyang, ChinaDepartment of Medicine-Cardiovascular, Guizhou Provincial People’s Hospital, Guiyang, ChinaDepartment of Digestive, People's Hospital of Songtao Miao Autonomous County, Tongren, ChinaDepartment of Oncology, Guizhou Provincial People’s Hospital, Guiyang, ChinaDepartment of Digestive, People's Hospital of Songtao Miao Autonomous County, Tongren, ChinaDepartment of Digestive, People's Hospital of Songtao Miao Autonomous County, Tongren, ChinaDepartment of Oncology, Guizhou Provincial People’s Hospital, Guiyang, ChinaDepartment of Oncology, Guizhou Provincial People’s Hospital, Guiyang, ChinaGuizhou University of Traditional Chinese Medicine, Guiyang, ChinaGuizhou University of Traditional Chinese Medicine, Guiyang, ChinaZunyi Medical University, Zunyi, ChinaDepartment of Digestive, People's Hospital of Songtao Miao Autonomous County, Tongren, ChinaDepartment of Oncology, Guizhou Provincial People’s Hospital, Guiyang, ChinaColorectal cancer is a common malignancy, and the incidence and mortality rates continue to rise. An important factor in the emergence of inflammation-induced colorectal carcinogenesis is elevated cyclooxygenase-2. Prostaglandin E2 (PGE2) over-production is frequently equated with cyclooxygenase-2 gene over-expression. PGE2 can be assessed by measuring the level of prostaglandin’s main metabolite, PGE-M, in urine. Colorectal adenoma is a precancerous lesion that can lead to colorectal cancer. We conducted research to evaluate the association between urinary levels of the PGE-M and the risk of colorectal adenomas. In a western Chinese population, we identified 152 cases of adenoma and 152 controls patients without polyps. Adenoma cases were categorized into control, low-risk and high-risk groups. There was no significant change in PGE-M levels, between the control group and the low-risk adenoma group. In the high-risk group, the PGE-M levels were 23% higher than the control group. When compared to people with the lowest urine PGE-M levels (first quartile), people with greater urinary PGE-M levels had a higher chance of developing high-risk colorectal adenomas, with an adjusted odds ratio (95% CI) of 1.65 (0.76-3.57) in the fourth quartile group, (p= 0.013). We conclude urinary PGE-M is associated with the risk of developing high-risk adenomas. Urinary PGE-M level may be used as a non-invasive indicator for estimating cancer risk.https://www.frontiersin.org/articles/10.3389/fonc.2023.1068469/fullcolorectal adenomaprostaglandin E2PGE-MColorectal cancercancer riskbio-markers
spellingShingle Jia Jiang
Anjie Li
Xiaolian Lai
Hanqun Zhang
Chonghong Wang
Huimin Wang
Libo Li
Yuncong Liu
Lu Xie
Can Yang
Cui Zhang
Shuoyan Lu
Yong Li
Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomas
Frontiers in Oncology
colorectal adenoma
prostaglandin E2
PGE-M
Colorectal cancer
cancer risk
bio-markers
title Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomas
title_full Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomas
title_fullStr Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomas
title_full_unstemmed Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomas
title_short Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomas
title_sort correlation between metabolite of prostaglandin e2 and the incidence of colorectal adenomas
topic colorectal adenoma
prostaglandin E2
PGE-M
Colorectal cancer
cancer risk
bio-markers
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1068469/full
work_keys_str_mv AT jiajiang correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas
AT anjieli correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas
AT xiaolianlai correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas
AT hanqunzhang correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas
AT chonghongwang correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas
AT huiminwang correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas
AT liboli correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas
AT yuncongliu correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas
AT luxie correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas
AT canyang correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas
AT cuizhang correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas
AT shuoyanlu correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas
AT yongli correlationbetweenmetaboliteofprostaglandine2andtheincidenceofcolorectaladenomas